IRIS - Res&Arch Institutional Research Information System - Research & Archive

CARDINALI, VALERIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 891
AS - Asia 622
EU - Europa 451
SA - Sud America 81
Continente sconosciuto - Info sul continente non disponibili 39
AF - Africa 18
OC - Oceania 3
Totale 2.105
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 837
SG - Singapore 266
IT - Italia 189
HK - Hong Kong 97
CN - Cina 78
VN - Vietnam 65
BR - Brasile 61
RU - Federazione Russa 56
KR - Corea 42
IE - Irlanda 39
DE - Germania 37
CA - Canada 24
FR - Francia 23
BD - Bangladesh 22
FI - Finlandia 22
GB - Regno Unito 17
AT - Austria 11
AR - Argentina 10
NL - Olanda 10
CZ - Repubblica Ceca 9
IN - India 8
SE - Svezia 7
ES - Italia 6
MX - Messico 6
PL - Polonia 6
CR - Costa Rica 5
GT - Guatemala 5
IQ - Iraq 5
PK - Pakistan 5
RO - Romania 5
TR - Turchia 5
ZA - Sudafrica 5
AZ - Azerbaigian 4
CO - Colombia 4
KZ - Kazakistan 4
SC - Seychelles 4
UA - Ucraina 4
UZ - Uzbekistan 4
EC - Ecuador 3
EG - Egitto 3
IL - Israele 3
LT - Lituania 3
NI - Nicaragua 3
AL - Albania 2
AU - Australia 2
CL - Cile 2
ET - Etiopia 2
GD - Grenada 2
ID - Indonesia 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
PA - Panama 2
TT - Trinidad e Tobago 2
AO - Angola 1
BE - Belgio 1
BH - Bahrain 1
BS - Bahamas 1
CH - Svizzera 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
JP - Giappone 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
SA - Arabia Saudita 1
SV - El Salvador 1
TM - Turkmenistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 2.067
Salva come PNG Salva come JPEG
Città #
Singapore 186
San Jose 125
Ashburn 101
Hong Kong 97
Perugia 73
Seoul 42
Dublin 39
Santa Clara 38
Boardman 36
Chandler 33
Council Bluffs 32
Munich 25
Ho Chi Minh City 24
Los Angeles 22
Moscow 21
New York 21
Lauterbourg 19
Dallas 18
Piscataway 18
Turku 16
Hanoi 12
San Mateo 10
The Dalles 9
Montreal 8
Beijing 7
Chicago 7
Denver 7
Orem 7
Rome 7
Brooklyn 6
Buffalo 6
Cagliari 6
Hefei 6
Medford 6
Nuremberg 6
Phoenix 6
Princeton 6
San Francisco 6
Vicenza 6
Vienna 6
Altamura 5
Guangzhou 5
Helsinki 5
Johannesburg 5
Lawrence 5
London 5
Mexico City 5
Milan 5
Riverbank 5
San José 5
São Paulo 5
Warsaw 5
Amsterdam 4
Andover 4
Atlanta 4
Bologna 4
Charlotte 4
Dhaka 4
Florence 4
Guatemala City 4
Lucca 4
Manchester 4
Olomouc 4
Stockholm 4
Tashkent 4
Toronto 4
Arezzo 3
Baghdad 3
Baku 3
Belo Horizonte 3
Brno 3
Frankfurt am Main 3
Managua 3
New Orleans 3
North Bergen 3
Palermo 3
Redmond 3
Tanta 3
Wilmington 3
Almaty 2
Amman 2
Ancona 2
Barnet 2
Buenos Aires 2
Bắc Ninh 2
Calgary 2
Changsha 2
Chennai 2
Chiajna 2
Collazzone 2
Columbia 2
Gijón 2
Haiphong 2
Itaquaquecetuba 2
Jacksonville 2
Lahore 2
Livorno 2
Milwaukee 2
Măgurele 2
Nairobi 2
Totale 1.323
Salva come PNG Salva come JPEG
Nome #
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure 225
Immune correlates of protection by vaccine against SARS-CoV-2 in patients with chronic lymphocytic leukaemia 178
High-Risk Clonal Hematopoiesis as the Origin of AITL and NPM1-Mutated AML 121
Dactinomycin induces complete remission associated with nucleolar stress response in relapsed/refractory NPM1-mutated AML 121
Current status and future perspectives in targeted therapy of NPM1-mutated AML 109
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs) 108
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML 107
Case Report: Contrasting BCL2 Upregulation With Venetoclax in a Case of Refractory Lymphomatoid Papulosis and Progressive Chronic Lymphocytic Leukemia 107
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation 98
Venetoclax plus azacitidine as genetic-driven bridge-to-transplant therapy for IDH2-mutated acute myeloid leukaemia (AML) refractory to intensive chemotherapy: proof-of-concept case reports 90
One disease, two faces: clonally-related AML and MPDCP with skin involvement 88
Enasidenib and ivosidenib in AML. 85
Starry sky pattern predicts RAS pathway activation in NPM1‐mutated acute myeloid leukemia 78
A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study 76
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies 73
Correction to: One disease, two faces: clonally-related AML and MPDCP with skin involvement 71
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia 68
Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase 67
Safe administration of venetoclax-obinutuzumab in a chronic lymphocytic leukemia patient with Brugada syndrome 66
NPM1-mutated AML with starry sky pattern 61
Omacetaxine mepessucinate plus venetoclax show strong synergistic anti-leukemic activity in nucleophosmin (NPM1)-mutated AML patient-derived xenograft (PDX) models to support a phase 1 clinical trial 41
Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia 39
A Chemo-Free Bridge-to-Transplant Strategy with Venetoclax and Azacitidine for NPM1-Mutated Acute Myeloid Leukemia in Molecular Failure 28
Totale 2.105
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.000
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202255 0 0 0 0 1 1 0 9 3 8 27 6
2022/2023119 5 19 2 5 13 10 12 3 41 2 6 1
2023/2024142 3 4 4 2 0 1 45 0 26 5 14 38
2024/2025442 32 33 12 18 58 35 37 40 76 30 43 28
2025/2026910 66 65 46 128 128 87 127 51 94 69 33 16
2026/2027410 32 135 61 157 25 0 0 0 0 0 0 0
Totale 2.105